Literature DB >> 2066944

Procainamide inhibits DNA methyltransferase in a human T cell line.

L S Scheinbart1, M A Johnson, L A Gross, S R Edelstein, B C Richardson.   

Abstract

Procainamide, a widely used antiarrythmic, causes DNA hypomethylation in the human T cell line Jurkat, but the mechanism is unknown. We report that procainamide inhibits the DNA methyltransferase catalyzed transfer of methyl groups from S-adenosylmethionine to DNA, but has no effect on other known regulators of DNA methylation. Our results suggest that procainamide could inhibit cellular DNA methylation by inhibiting DNA methyltransferase activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2066944

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  34 in total

Review 1.  Environmental exposures, epigenetic changes and the risk of lupus.

Authors:  E C Somers; B C Richardson
Journal:  Lupus       Date:  2014-05       Impact factor: 2.911

Review 2.  Environmental Basis of Autoimmunity.

Authors:  Annarosa Floreani; Patrick S C Leung; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

3.  Metabolomics reveals the metabolic map of procainamide in humans and mice.

Authors:  Fei Li; Andrew D Patterson; Kristopher W Krausz; Bernhard Dick; Felix J Frey; Frank J Gonzalez; Jeffrey R Idle
Journal:  Biochem Pharmacol       Date:  2012-02-24       Impact factor: 5.858

4.  T cell PKCδ kinase inactivation induces lupus-like autoimmunity in mice.

Authors:  Gabriela Gorelik; Amr H Sawalha; Dipak Patel; Kent Johnson; Bruce Richardson
Journal:  Clin Immunol       Date:  2015-03-28       Impact factor: 3.969

5.  Epigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agents.

Authors:  Matlock A Jeffries; Amr H Sawalha
Journal:  Int J Clin Rheumtol       Date:  2011-08

Review 6.  Possible Reversal of PTSD-Related DNA Methylation by Sympathetic Blockade.

Authors:  Eugene G Lipov; Kenneth Candido; Elspeth C Ritchie
Journal:  J Mol Neurosci       Date:  2017-03-31       Impact factor: 3.444

7.  Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice.

Authors:  J Quddus; K J Johnson; J Gavalchin; E P Amento; C E Chrisp; R L Yung; B C Richardson
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

Review 8.  Key role of ERK pathway signaling in lupus.

Authors:  Gabriela Gorelik; Bruce Richardson
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

9.  Cytokine-induced monocyte characteristics in SLE.

Authors:  Zhe Zhang; Kelly Maurer; Juan C Perin; Li Song; Kathleen E Sullivan
Journal:  J Biomed Biotechnol       Date:  2010-06-24

10.  Epigenetics, behaviour, and health.

Authors:  Moshe Szyf; Michael J Meaney
Journal:  Allergy Asthma Clin Immunol       Date:  2008-03-15       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.